BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18692480)

  • 41. The effects of clofazimine, niclosamide & amphotericin B, on electron transport of Leishmania donovani promastigotes.
    Datta G; Bera T
    Indian J Med Res; 2000 Jul; 112():15-20. PubMed ID: 11006656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antiprotozoal activity of 4-arylcoumarins.
    Pierson JT; Dumètre A; Hutter S; Delmas F; Laget M; Finet JP; Azas N; Combes S
    Eur J Med Chem; 2010 Mar; 45(3):864-9. PubMed ID: 19914747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Programmed cell death in the unicellular protozoan parasite Leishmania.
    Lee N; Bertholet S; Debrabant A; Muller J; Duncan R; Nakhasi HL
    Cell Death Differ; 2002 Jan; 9(1):53-64. PubMed ID: 11803374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antileishmanial effect of a potent S-adenosylmethionine decarboxylase inhibitor: CGP 40215A.
    Mukhopadhyay R; Kapoor P; Madhubala R
    Pharmacol Res; 1996 Jan; 33(1):67-70. PubMed ID: 8817649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
    Samant M; Sahasrabuddhe AA; Singh N; Gupta SK; Sundar S; Dube A
    Parasitology; 2007 Aug; 134(Pt 9):1175-84. PubMed ID: 17362540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of agmatine transport in liver mitochondria by new charge-deficient agmatine analogues.
    Grillo MA; Battaglia V; Colombatto S; Rossi CA; Simonian AR; Salvi M; Khomutov AR; Toninello A
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):401-4. PubMed ID: 17371286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
    Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
    Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polyamine transport in parasites: a potential target for new antiparasitic drug development.
    Reguera RM; Tekwani BL; Balaña-Fouce R
    Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):151-64. PubMed ID: 15907761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of metacaspases with trypsin-like activity and their putative role in programmed cell death in the protozoan parasite Leishmania.
    Lee N; Gannavaram S; Selvapandiyan A; Debrabant A
    Eukaryot Cell; 2007 Oct; 6(10):1745-57. PubMed ID: 17715367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo monitoring of intracellular ATP levels in Leishmania donovani promastigotes as a rapid method to screen drugs targeting bioenergetic metabolism.
    Luque-Ortega JR; Rivero-Lezcano OM; Croft SL; Rivas L
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1121-5. PubMed ID: 11257025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistance to arsenite modulates expression of beta- and gamma-tubulin and sensitivity to paclitaxel during differentiation of Leishmania donovani.
    Jayanarayan KG; Dey CS
    Parasitol Res; 2002 Aug; 88(8):754-9. PubMed ID: 12122434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis and in vitro antikinetoplastid evaluation of N-acylated putrescine, spermidine and spermine derivatives.
    Jagu E; Djilali R; Pomel S; Ramiandrasoa F; Pethe S; Labruère R; Loiseau PM; Blonski C
    Bioorg Med Chem Lett; 2015 Jan; 25(2):207-9. PubMed ID: 25499437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
    Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
    Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crucial role of cytosolic tryparedoxin peroxidase in Leishmania donovani survival, drug response and virulence.
    Iyer JP; Kaprakkaden A; Choudhary ML; Shaha C
    Mol Microbiol; 2008 Apr; 68(2):372-91. PubMed ID: 18312262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Redox-active dinitrodiphenylthioethers against Leishmania: synthesis, structure-activity relationships and mechanism of action studies.
    Delfín DA; Morgan RE; Zhu X; Werbovetz KA
    Bioorg Med Chem; 2009 Jan; 17(2):820-9. PubMed ID: 19058972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antileishmanial activity mediated by apoptosis and structure-based target study of peganine hydrochloride dihydrate: an approach for rational drug design.
    Misra P; Khaliq T; Dixit A; SenGupta S; Samant M; Kumari S; Kumar A; Kushawaha PK; Majumder HK; Saxena AK; Narender T; Dube A
    J Antimicrob Chemother; 2008 Nov; 62(5):998-1002. PubMed ID: 18694906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mianserin, an antidepressant kills Leishmania donovani by depleting ergosterol levels.
    Dinesh N; Kaur PK; Swamy KK; Singh S
    Exp Parasitol; 2014 Sep; 144():84-90. PubMed ID: 24950381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leishmania donovani: cellular control of ornithine decarboxylase in promastigotes.
    Mukhopadhyay R; Madhubala R
    Int J Biochem Cell Biol; 1995 Sep; 27(9):947-52. PubMed ID: 7584631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcriptome analysis of agmatine and putrescine catabolism in Pseudomonas aeruginosa PAO1.
    Chou HT; Kwon DH; Hegazy M; Lu CD
    J Bacteriol; 2008 Mar; 190(6):1966-75. PubMed ID: 18192388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uptake into leishmania donovani promastigotes and antileishmanial action of an organometallic complex derived from pentamidine.
    Mbongo N; Loiseau PM; Lawrence F; Craciunescu DG; Robert-Gero M
    Arzneimittelforschung; 1998 Aug; 48(8):850-5. PubMed ID: 9748715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.